Hoth Therapeutics, Inc.
$0.74
▲
2.65%
2026-04-21 07:20:01
hoththerapeutics.com
NCM: HOTH
Explore Hoth Therapeutics, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$13.96 M
Current Price
$0.74
52W High / Low
$2.12 / $0.49
Stock P/E
—
Book Value
$0.4
Dividend Yield
—
ROCE
-200.97%
ROE
-1.91%
Face Value
—
EPS
$-0.9
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
2
Beta
0.6
Debt / Equity
0.09
Current Ratio
4.72
Quick Ratio
4.72
Forward P/E
-0.73
Price / Sales
—
Enterprise Value
$2.14 M
EV / EBITDA
—
EV / Revenue
—
Rating
None
Target Price
$5
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Quantum BioPharma Ltd. | $3.12 | — | $25.24 M | — | -300.19% | -3.47% | $52 / $2.85 | $1.81 |
| 2. | Precision BioSciences, Inc. | $7.58 | — | $187.43 M | — | -35.84% | -62.71% | $8.82 / $3.53 | $3.83 |
| 3. | CalciMedica, Inc. | $0.66 | — | $9.49 M | — | -235.71% | -7.61% | $7.2 / $0.46 | $-0.43 |
| 4. | Nkarta, Inc. | $3.49 | — | $247.38 M | — | -31.94% | -28.9% | $3.48 / $1.63 | $4.39 |
| 5. | Canton Strategic Holdings, Inc. | $3.51 | — | $194.33 M | — | -3.9% | -17.99% | $9.08 / $1.05 | $10.72 |
| 6. | Phathom Pharmaceuticals, Inc. | $13.47 | — | $1.04 B | — | -125.87% | 63.97% | $18.31 / $2.21 | $-6.13 |
| 7. | Genprex, Inc. | $1.16 | — | $10.45 M | — | -194.32% | -3.39% | $55 / $1.15 | $3.78 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -2.61 M | -4.08 M | -2.2 M | -3.48 M | -2.38 M | — |
| Net Profit | -2.69 M | -4.11 M | -2.2 M | -3.48 M | -2.38 M | — |
| EPS in Rs | -0.14 | -0.21 | -0.11 | -0.18 | -0.12 | -0.32 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -12.36 M | -8.22 M | -7.95 M | -11.07 M |
| Net Profit | -12.47 M | -8.19 M | -8.11 M | -11.37 M |
| EPS in Rs | -0.65 | -0.43 | -0.42 | -0.59 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 7.6 M | 7.71 M | 10.24 M | 6.76 M |
| Total Liabilities | 1.45 M | 0.83 M | 0.7 M | 1.64 M |
| Equity | 6.15 M | 6.88 M | 9.54 M | 5.12 M |
| Current Assets | 6.86 M | 7.64 M | 10.15 M | 6.73 M |
| Current Liabilities | 1.45 M | 0.83 M | 0.68 M | 1.39 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -9.8 M | -6.98 M | -8.45 M | -9.3 M |
| Investing CF | -0.3 M | 0 M | 0 M | 1.16 M |
| Financing CF | 9.31 M | 4.74 M | 11.32 M | 6.04 M |
| Free CF | -9.8 M | -6.98 M | -8.45 M | -9.37 M |
| Capex | — | — | — | -0.07 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | -1.01% | 28.72% | — | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2022-10-26 | 1:0.04 |